{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:29:05Z","timestamp":1788805745377,"version":"build-2803163510"},"reference-count":27,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Romanian Society of Dermatology","award":["507\/24.07.2018"],"award-info":[{"award-number":["507\/24.07.2018"]}]},{"name":"Abbvie SRL","award":["8940\/05.12.2018"],"award-info":[{"award-number":["8940\/05.12.2018"]}]},{"name":"Eli Lilly Romania SRL","award":["112\/28.06.2018"],"award-info":[{"award-number":["112\/28.06.2018"]}]},{"name":"Novartis Pharma Services Romania","award":["20193447\/06.11.2019"],"award-info":[{"award-number":["20193447\/06.11.2019"]}]},{"name":"Johnson&amp;Johnson Romania","award":["223\/06.12.2018"],"award-info":[{"award-number":["223\/06.12.2018"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background: Psoriasis is a chronic inflammatory disease characterized by an excessive hyperproliferation of keratinocytes and a combination of genetic, epigenetic, and environmental influences. The pathogenesis of psoriasis is complex and the exact mechanism remains elusive. Objectives: The study of the prevalence of psoriasis will allow the estimation of the number of people suffering from this condition at the national level, as well as the development and validation of a questionnaire to estimate the prevalence and the risk factors associated with the disease. Methods: A quantitative research was conducted at a national level among the target population in order to validate the questionnaire and estimate the national prevalence. Results: Declaratively, the prevalence of psoriasis in the studied group (N = 1500) is 4%, the first symptoms appearing around the age of 50, with a certified diagnosis being made on average at 55 years. The prevalence of psoriasis vulgaris was 4.99%. Conclusions: The results obtained will be useful in guiding future initiatives and communication campaigns related to this condition, and the methodological approach used will provide the opportunity to make recommendations for improving similar initiatives in the future.<\/jats:p>","DOI":"10.3390\/jpm11060523","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T13:25:43Z","timestamp":1623072343000},"page":"523","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prevalence and Characteristics of Psoriasis in Romania\u2014First Study in Overall Population"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-464X","authenticated-orcid":false,"given":"Alin Codru\u021b","family":"Nicolescu","sequence":"first","affiliation":[{"name":"Roma Medical Center for Diagnosis and Treatment, 011773 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0218tefana","family":"Bucur","sequence":"additional","affiliation":[{"name":"III<sup>rd<\/sup> Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"II<sup>nd<\/sup> Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u0103lin","family":"Giurc\u0103neanu","sequence":"additional","affiliation":[{"name":"III<sup>rd<\/sup> Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Dermatology, Elias University Emergency Hospital, 011461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gheuc\u0103-Solov\u0103stru","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u201cSf. Spiridon\u201d Clinical Hospital, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5075-9758","authenticated-orcid":false,"given":"Traian","family":"Constantin","sequence":"additional","affiliation":[{"name":"III<sup>rd<\/sup> Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Urology, \u201cTh. Burghele\u201d Hospital, 050652 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentina","family":"Furtunescu","sequence":"additional","affiliation":[{"name":"III<sup>rd<\/sup> Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Public Health and Management, 050463 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioan","family":"Ancu\u021ba","sequence":"additional","affiliation":[{"name":"III<sup>rd<\/sup> Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Rheumatology, \u201cDr. I. Cantacuzino\u201d Clinical Hospital, 020475 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-3236","authenticated-orcid":false,"given":"Maria Magdalena","family":"Constantin","sequence":"additional","affiliation":[{"name":"III<sup>rd<\/sup> Department, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"II<sup>nd<\/sup> Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"ref_1","first-page":"385","article-title":"Epidemiology of Psoriasis. A Population-Based Study","volume":"110","year":"2019","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1440-0960.1998.tb01478.x","article-title":"A review of the epidemiology of psoriasis vulgaris in the community","volume":"39","author":"Plunkett","year":"1998","journal-title":"Australas. J. Dermatol."},{"key":"ref_4","unstructured":"(2021, May 06). International Federation of Psoriasis Associations. World Psoriasis Day. Available online: https:\/\/ifpa-pso.com\/our-actions\/world-psoriasis-day."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.12688\/f1000research.19144.1","article-title":"Psoriatic arthritis","volume":"8","author":"Gladman","year":"2019","journal-title":"F1000Research"},{"key":"ref_6","first-page":"47","article-title":"Psoriatic arthritis: A permanent new challenge for dermatologists (Review)","volume":"20","author":"Dinu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Barrea, L., Nappi, F., Di Somma, C., Savanelli, M.C., Falco, A., Balato, A., Balato, N., and Savastano, S. (2016). Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist. Int. J. Environ. Res. Public Health, 13.","DOI":"10.3390\/ijerph13070743"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Barrea, L., Megna, M., Cacciapuoti, S., Frias-Toral, E., Fabbrocini, G., Savastano, S., Colao, A., and Muscogiuri, G. (2020). Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: An update for dermatologists and nutritionists. Crit. Rev. Food Sci. Nutr., 1\u201317.","DOI":"10.1080\/10408398.2020.1818053"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00204-018-2193-0","article-title":"Coffee consumption, metabolic syndrome and clinical severity of psoriasis: Good or bad stuff?","volume":"92","author":"Barrea","year":"2018","journal-title":"Arch. Toxicol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11154-017-9411-6","article-title":"Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist","volume":"18","author":"Barrea","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_11","unstructured":"National Institute of Statistics (2020, April 13). Tempo Online Statistics. Available online: http:\/\/statistici.insse.ro:8077\/tempo-online\/#\/pages\/tables\/insse-table."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1468-3083.2001.00192.x","article-title":"The prevalence of psoriasis in the world","volume":"15","author":"Raychaudhuri","year":"2001","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/jdv.15762","article-title":"Incidence and prevalence of psoriasis in Israel between 2011 and 2017","volume":"33","author":"Schonmann","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1468-3083.1998.tb00711.x","article-title":"A clinical survey of psoriasis in Italy: 1st AISP report. Interdisciplinary Association for the Study of Psoriasis","volume":"10","author":"Finzi","year":"1998","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1468-3083.2001.00191.x","article-title":"Prevalence of psoriasis in Spain (Epiderma Project: Phase I)","volume":"15","author":"Ferrandiz","year":"2001","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/jdv.15450","article-title":"Itch: An under-recognized problem in psoriasis","volume":"33","author":"Elewski","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jdv.14460","article-title":"Depression and suicidality in psoriasis: Review of the literature including the cytokine theory of depression","volume":"31","author":"Koo","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"P142","DOI":"10.1016\/j.jaad.2003.10.493","article-title":"A comparison of biologic therapies for psoriasis","volume":"50","author":"Abramovits","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","first-page":"918","article-title":"Original clinical experience and approach to treatment study with interleukine 12\/23 inhibitor in moderate-to-severe psoriasis patients","volume":"64","author":"Olteanu","year":"2016","journal-title":"Farmacia"},{"key":"ref_20","first-page":"911","article-title":"Biosimilars in dermatology: The wind of change","volume":"18","author":"Constantin","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_21","first-page":"57","article-title":"Biosimilars: An Update on Clinical Trials (Review of Published and Ongoing Studies)","volume":"25","author":"Olteanu","year":"2017","journal-title":"Acta Dermatovenerol. Croat. ADC"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e14504","DOI":"10.1111\/dth.14504","article-title":"Emerging role of anti-IL23 in the treatment of psoriasis: When humanized is very promising","volume":"33","author":"Dattola","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Iannone, L.F., Bennardo, L., Palleria, C., Roberti, R., De Sarro, C., Naturale, M.D., Dastoli, S., Donato, L., Manti, A., and Valenti, G. (2020). Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241575"},{"key":"ref_24","first-page":"895","article-title":"Therapeutic management with biological anti-TNF-\u03b1 agent in severe psoriasis associated with chronic hepatitis B: A case report","volume":"18","author":"Raducan","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/jdv.14310","article-title":"Increased prevalence of HCV and hepatic decompensation in adults with psoriasis: A population-based study in the United Kingdom","volume":"31","author":"Noe","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jdv.16029","article-title":"Psoriasis, cardiovascular risk factors and metabolic disorders: Sex-specific findings of a population-based study","volume":"34","author":"Sondermann","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Stewart, T.J., Tong, W., and Whitfeld, M. (2018). The associations between psychological stress and psoriasis: A systematic review. Int. J. Dermatol., 57.","DOI":"10.1111\/ijd.13956"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/6\/523\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:11:35Z","timestamp":1760163095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/6\/523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["jpm11060523"],"URL":"https:\/\/doi.org\/10.3390\/jpm11060523","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]}}}